全文获取类型
收费全文 | 22329篇 |
免费 | 2418篇 |
国内免费 | 404篇 |
专业分类
耳鼻咽喉 | 406篇 |
儿科学 | 1057篇 |
妇产科学 | 1148篇 |
基础医学 | 2207篇 |
口腔科学 | 245篇 |
临床医学 | 2252篇 |
内科学 | 3400篇 |
皮肤病学 | 186篇 |
神经病学 | 1063篇 |
特种医学 | 647篇 |
外国民族医学 | 3篇 |
外科学 | 1579篇 |
综合类 | 1554篇 |
现状与发展 | 2篇 |
预防医学 | 3254篇 |
眼科学 | 531篇 |
药学 | 2308篇 |
13篇 | |
中国医学 | 455篇 |
肿瘤学 | 2841篇 |
出版年
2024年 | 233篇 |
2023年 | 512篇 |
2022年 | 856篇 |
2021年 | 1127篇 |
2020年 | 1083篇 |
2019年 | 1060篇 |
2018年 | 973篇 |
2017年 | 944篇 |
2016年 | 997篇 |
2015年 | 973篇 |
2014年 | 1494篇 |
2013年 | 2031篇 |
2012年 | 1208篇 |
2011年 | 1289篇 |
2010年 | 1028篇 |
2009年 | 1002篇 |
2008年 | 1022篇 |
2007年 | 958篇 |
2006年 | 825篇 |
2005年 | 684篇 |
2004年 | 562篇 |
2003年 | 552篇 |
2002年 | 385篇 |
2001年 | 354篇 |
2000年 | 253篇 |
1999年 | 264篇 |
1998年 | 227篇 |
1997年 | 209篇 |
1996年 | 158篇 |
1995年 | 149篇 |
1994年 | 136篇 |
1993年 | 108篇 |
1992年 | 119篇 |
1991年 | 87篇 |
1990年 | 96篇 |
1989年 | 64篇 |
1988年 | 66篇 |
1987年 | 60篇 |
1985年 | 80篇 |
1984年 | 54篇 |
1982年 | 51篇 |
1981年 | 55篇 |
1980年 | 63篇 |
1979年 | 56篇 |
1978年 | 69篇 |
1977年 | 61篇 |
1976年 | 133篇 |
1975年 | 115篇 |
1974年 | 79篇 |
1973年 | 85篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
《Health policy (Amsterdam, Netherlands)》2018,122(4):422-430
This study is an in-depth examination of at whose initiative (participant, physician or screening programme) individuals participate in cervical, breast and colorectal cancer screening across the EU-28. Special attention is paid to (1) the association with educational attainment and (2) the country’s cancer screening strategy (organised, pilot/regional or opportunistic) for each type of cancer screened. Data were obtained from Eurobarometer 66.2 ‘Health in the European Union’ (2006). Final samples consisted of 10,186; 5443 and 9851 individuals for cervical, breast, and colorectal cancer, respectively. Multinomial logistic regressions were performed. Surprisingly, even in countries with organised screening programmes, participation in screenings for cervical, breast and colorectal cancer was most likely to be initiated by the general practitioner (GP) or the participant. In general, GPs were found to play a crucial role in making referrals to screenings, regardless of the country’s screening strategy. The results also revealed differences between educational groups with regard to their incentive to participate in cervical and breast cancer screening and, to a lesser extent, in colorectal cancer screening. People with high education are more likely to participate in cancer screening at their own initiative, while people with less education are more likely to participate at the initiative of a physician or a screening programme. Albeit, the results varied according to type of cancer screening and national screening strategy. 相似文献
15.
16.
目的探寻一种简便的恶性肿瘤初筛自查方法。方法将人体肿瘤分为三类:体表肿瘤约占15%;空腔脏器肿瘤占65%;深层实体脏器肿瘤20%。通过科普宣传教育,让群众学会自查体表部位肿瘤,每年用自查盒助查各空腔脏器有无微量出血,隐血阳性时,去医院进一步精查。北京部分大学选40~70岁居民1万人,分成试验组、对照组各5千人。结果试验四年后:试验组共查出79例癌,年平均癌检出率482.5人/10万,癌死亡率为12.2/10万;对照组癌死亡率206.2人/10万,两组有显著性差异。在癌症高发区,同时作扩大普查试验:广东四会市肿瘤所,在门诊普查1669人,检出25例癌,鼻咽癌占24例。1999~2000年,江苏省食管胃癌高发区,普查近8万人,检出480例癌。加上“九五”以前的普查统计,用秦氏自查盒已筛查431075人,检出1272例癌,癌前病变1万多例。结论试验证明该方案设计合理,在当前是一种最简便的恶性肿瘤初筛自查方法。 相似文献
17.
Yingshan Han Hanh T. Pham Hongtao Xu Yudong Quan Thibault Mesplède 《Journal of medical virology》2019,91(7):1182-1190
Studies aimed at repurposing existing drugs revealed that some antimalarial compounds possess anti-Zika virus (anti-ZIKV) activity. Here, we further tested 14 additional antimalarial drugs and their metabolites or analogs for anti-ZIKV activity using a phenotypic screening approach. We identified four compounds with varying anti-ZIKV activity, including a metabolite of amodiaquine termed desethylamodiaquine (DAQ) and N-desethylchloroquine (DECQ), a metabolite of chloroquine, which both exhibited low micromolar effective concentrations against three different ZIKV strains. Two other compounds termed dihydroartemisinin (DHA) and quinidine (QD) exhibited only partial inhibition of ZIKV replication. Characterization of the inhibitory mechanisms of DAQ and DECQ showed that both drugs target the entry step as well as postentry events of the viral replication cycle. These hits represent attractive starting points for future optimization of new anti-ZIKV drug candidates derived from antimalarial drugs and their analogs. 相似文献
18.
Christian von Wagner Yasemin Hirst Jo Waller Alex Ghanouni Lesley M. McGregor Robert S. Kerrison Wouter Verstraete Ivo Vlaev Monika Sieverding Sandro T. Stoffel 《Patient education and counseling》2019,102(9):1621-1628
ObjectiveThe current study tested in two online experiments whether manipulating normative beliefs about cancer screening uptake increases intention to attend colorectal screening among previously disinclined individuals.Methods2461 men and women from an Internet panel (Experiment 1 N = 1032; Experiment 2, N = 1423) who initially stated that they did not intend to take up screening were asked to guess how many men and women they believe to get screened for colorectal cancer. Across participants, we varied the presence/absence of feedback on the participant’s estimate, as well as the stated proportion of men and women doing the screening test.ResultsAcross the two experiments, we found that receiving one of the experimental messages stating that uptake is higher than estimated significantly increased the proportion of disinclined men and women becoming intenders. While, we found a positive relationship between the communicated uptake and screening intentions, we did not find evidence that providing feedback on the estimate has an added benefit.ConclusionScreening intention can be effectively manipulated through a high uptake message.Practice implicationsCommunication of high screening uptake is an easy and effective way to motivate disinclined individuals to engage in colorectal cancer screening. 相似文献
19.
Henk Broekhuizen Catharina G.M. Groothuis-Oudshoorn Rozemarijn Vliegenthart Harry J.M. Groen Maarten J. IJzerman 《Value in health》2018,21(11):1269-1277
Background
Lung cancer screening can reduce cancer mortality. Most implementation studies focus only on low-dose computed tomography (LDCT) and clinical attributes of screening and do not include preferences of potential participants. In this study we evaluated the perceived value of screening programs based on LDCT, breath analysis (BA), or blood biomarkers (BB) according to the perspective of the target population.Methods
A multi-criteria decision analysis framework was adopted. The weights of seven attributes of screening (sensitivity, specificity, radiation burden, duration of screening process, waiting time until results are communicated, location of screening, and mode of screening) were obtained from an earlier study that included a broad sample from the Netherlands. Performance data for the screening modalities was obtained from clinical trials and expert opinion. Parameter uncertainty about clinical performances was incorporated probabilistically, while heterogeneity in preferences was analyzed through subgroup analyses.Results
The mean overall values were 0.58 (CI: 0.57 to 0.59), 0.57 (CI: 0.56 to 0.59), and 0.44 (CI: 0.43 to 0.45) for BB, BA, and LDCT, respectively. Seventy-seven per cent of respondents preferred BB or BA. For most subgroups, the overall values were similar to those of the entire sample. BA had the highest value for respondents who would have been eligible for earlier screening trials.Discussion
BB and BA seem valuable to participants because they can be applied in a primary care setting. Although LDCT still seems preferable given its strong and positive evidence base, it is important to take non-clinical attributes into account to maximize attendance. 相似文献20.
Amélie Aïm-Eusébi Emmanuel Prothon Catherine Majerholc Diana Barger Yazdan Yazdanpanah Jean-Pierre Aubert 《The European journal of general practice》2018,24(1):60-67
Background: Many people in Europe remain undiagnosed for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV).Objectives: To evaluate acceptability and effectiveness of a questionnaire designed to facilitate identification of risk factors for these viruses.Methods: We performed an observational study, in a prospectively enrolled cohort of patients in Paris (France) seen in 2014. Eighteen GPs administered a questionnaire to the first 50 patients, collecting information about risk factors. GPs were randomized into two groups: A (self-administered questionnaire) and B (GP-administered questionnaire). We used the overall response rate to assess the acceptability of the questionnaire. We used the rate of newly identified risk factors and compared the number of tests performed one year before and immediately after the intervention to assess the effectiveness of the questionnaire.Results: 842 patients were randomized: 349 (41.5%) in group A and 493 (58.5%) in group B. Acceptability was 88.5% (95%CI: 86.3–90.6); 93.1% (95%CI: 90.5–95.8) in-group A and 85.2% (95%CI: 82.1–88.3) in group B (P?=?0.0004). Prevalence of risk factors was 51.8% (95%CI: 48.2–54.4) and 58.3% were newly identified (95%CI: 52.9–63.7). The number of HIV tests performed during the four weeks after intervention increased by 27% compared to the same period one year before (P?=?0.22). It increased by 113% (P?=?0.005) and 135% (P?=?0.005) for HBV and HCV, respectively.Conclusion: The questionnaire proved acceptable and effective in identifying risk factors for HIV, HBV and HCV in general practice. 相似文献